SuperworthDare Bioscience shares outstanding DARE
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Jun 30, 2026
- 14.9M
- On a year earlier
- +67.8%
- more shares
Dare Bioscience had 14.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 67.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 14.3M | +78% |
| FY2024 | 8M | +10% |
| FY2023 | 7.3M | +7% |
| FY2022 | 6.8M | +57% |
| FY2021 | 4.3M | +37% |
| FY2020 | 3.2M | +112% |
| FY2019 | 1.5M | +58% |
| FY2018 | 951.8K | +89% |
| FY2017 | 503.9K | +111% |
| FY2016 | 239.4K | +5% |
| FY2015 | 227.9K | +36% |
| FY2014 | 167.7K | +2472% |
| FY2013 | 6.5K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 14.9M | +68% | |
| Q1 FY26 | 14.5M | +66% | |
| Q4 FY25 | 14.3M | +78% | |
| Q3 FY25 | 12.8M | +49% | |
| Q2 FY25 | 8.9M | +5% | |
| Q1 FY25 | 8.8M | +5% | |
| Q4 FY24 | 8M | +10% | |
| Q3 FY24 | 8.5M | +12% | |
| Q2 FY24 | 8.5M | +18% | |
| Q1 FY24 | 8.4M | +18% | |
| Q4 FY23 | 7.3M | +7% | |
| Q3 FY23 | 7.6M | +7% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Dare Bioscience
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.